Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Heart

Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy

View Full Paper
Ask AI
Bookmark
Share

Authors

SSStephan A C SchoonveldePZPeter-Paul ZwetslootAHAlexander Hirsch

Discussion

Loading...

Member takes

Overview

Observational analysis shows lower physical activity and poorer quality of life in hypertrophic cardiomyopathy patients, suggesting need for tailored exercise guidance.

Key Points

  • Patients with hypertrophic cardiomyopathy took significantly fewer steps per day compared to genotype-positive controls, averaging 5,254 steps.
  • A reduction in physical activity was notably linked to poorer quality of life scores, as indicated by the Kansas City Cardiomyopathy Questionnaire.
  • The study utilized accelerometry data to categorize physical activity, highlighting the sedentary lifestyle prevalent among symptomatic HCM patients.
  • Individualized exercise counseling may improve quality of life outcomes, given the strong association between daily step counts and quality of life metrics.

Cite This Study

Schoonvelde et al. (2025) studied this question.

synapsesocial.com/papers/68c23966b210217d6477bb24https://doi.org/10.1136/heartjnl-2025-326217
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-Term Prognostic Value of Cardiopulmonary Exercise Testing in Patients with Hypertrophic Cardiomyopathy2026
  2. 2Exercise training in hypertrophic cardiomyopathy: a meta-analysis of randomised trials with trial sequential analysis2025 · 1 citations
  3. 3Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐Analysis2025 · 16 citations
  4. 4Invasive exercise hemodynamics in obstructive and non-obstructive hypertrophic cardiomyopathy2026
  5. 5Human Activity Profile Questionnaire: functional assessment and screening for systolic dysfunction in patients with Chagas cardiomyopathy2025